𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer

✍ Scribed by Keshamouni, Venkateshwar G; Reddy, Raju C; Arenberg, Douglas A; Joel, Binju; Thannickal, Victor J; Kalemkerian, Gregory P; Standiford, Theodore J


Book ID
110067970
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
330 KB
Volume
23
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Activation of peroxisome proliferator-ac
✍ Mingyue Li; Tak W. Lee; Tony S.K. Mok; Timothy D. Warner; Anthony P.C. Yim; Geor 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

## Abstract Peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) is a member of the nuclear hormone receptor superfamily of ligand‐activated transcription factors and a crucial regulator of cellular differentiation. PPAR‐γ ligands have been demonstrated to inhibit growth of several cancer cell

Primary culture model of peroxisome prol
✍ Yue Xu; Sunita Iyengar; Richard L. Roberts; Scott B. Shappell; Donna M. Peehl 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

## Abstract BRL 49653 (rosiglitazone) is a thiazolidinedione anti‐diabetic drug that activates the nuclear receptor, peroxisome proliferator‐activated receptor gamma (PPARγ). Pilot clinical trials have shown evidence of therapeutic activity of PPARγ agonists against prostate cancer. To more effecti